An experienced immuno-oncology project leader with extensive knowledge and research experience in immunology, tumor immunology, immunotherapy, and signaling pathways. Thorough understating of different drug/treatment MOAs (small molecule inhibitors, CAR-T/NK-CAR, ADC, ICB, BiTE). Creative, meticulous, multi-tasking and problem-solving skills. Proven ability to lead projects, set objectives, use risk mitigations strategies, manage scientific collaborations and work with CROs. High presentation skills, presenting data to management, collaborators, and review meetings. Strong publication record in peer reviewed journals (close to 30 articles as a first author or co-author). Experience with a wide variety of cell and molecular biology techniques, biochemistry, flow cytometry, and familiarity with different in-vivo tumor models.Major achievements:• Generation of pre-clinical data that enabled a Go/No Go decision for various projects/targets.• Contributed to patent filing for GBM immunotherapy by data generation and writing of the results section.• Contributed to target discovery efforts by reviewing data and literature, and by actively collaborating with a computational team, bringing and advancing new ideas for target research.• Ad-Hoc Reviewer, Maryland Industrial Partnerships Program (MIPS)• Basic Science Instructor in Immunology in USU Summer Research Training Program• Creating original research projects that got funded through the successful receipt of NIH R01 grant ($1M funding)